4.6 Article

Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial

Related references

Note: Only part of the references are listed.
Article Hematology

Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)

Russell E. Ware et al.

BLOOD (2012)

Review Medicine, General & Internal

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease

Sophie Lanzkron et al.

ANNALS OF INTERNAL MEDICINE (2008)

Article Hematology

The pathophysiology, prevention, and treatment of stroke in sickle cell disease

Winfred C. Wang

CURRENT OPINION IN HEMATOLOGY (2007)

Article Hematology

Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2

Lori A. Styles et al.

BRITISH JOURNAL OF HAEMATOLOGY (2007)

Article Medicine, General & Internal

Causes and outcomes of the acute chest syndrome in sickle cell disease.

EP Vichinsky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)